0 results for 'Davis Polk'
The Sweet Spot Between Microaggressions and Empty Words: Threading the Needle on Associate Feedback
Law firms and partners may struggle to deliver appropriate guidance to rising attorneys while keeping diversity, equity, and inclusion standards in mind. But getting it wrong has real costs.
Former GSK Patent Leader Moves to Troutman Pepper
Duke Fitch started at the company as a medicinal chemist and rose to vice president of U.S. pharmaceutical patents after earning his law degree.
Which M&A Attorneys Drove the Most Business as Deal Leads?
The annual Mergerlinks rankings highlight the top dealmakers in Big Law.
Lawyers Need Proper HR Training to Be Better Supervisors and to Reduce Risk
In a law firm setting, issues often occur when policies are not enforced equally across the board or when there is no supporting documentation for performance complaints. These types of misalignment can lead to discrimination claims.
DC Firms Strive to Keep Up With New York on Associate Pay
"Many do compete with the New York firms," said Wells Fargo's Owen Burman about D.C. firms. "But it's not universal."
Law Journal Press | Digital Book
America Invents Act (AIA) Handbook: A Guide to the Patent Law Reform of 2011, The, 2015 Edition
Authors: Mary Anthony Merchant
View this Book
View more book results for the query "Davis Polk"
Deal Watch: Wachtell, Paul Weiss and V&E Lead $26B Oil Merger as Deal Activity Soars
Energy and life sciences continue to lead the way in deal activity, but tech and other recently nascent sectors are showing signs of life.
As Associate Pay Raises Divide the Market, Several Law Firms Match, Others Hold Off
"Many do compete with the New York firms," said Wells Fargo's Owen Burman about D.C. firms. "But it's not universal."
Litigator of the Week Runners-Up And Shout Outs
A team at Pillsbury Winthrop Shaw Pittman secured a ruling eliminating more than a half billion dollars in potential liability for client Teck Cominco Metals in a long-running environmental suit in the Eastern District of Washington.
US Firms Line Up Behind $16B Three-Way Drug Manufacturing Deal
Skadden, Goodwin Procter and Jones Day are behind the $16.5 billion acquisition of an American pharmaceutical company by the holding company of Novo Nordisk, maker of weight-loss drug Wegovy and Type 2 diabetes shot Ozempic.
Crypto Contract Clash Gets Second Look From Delaware Supreme Court En Banc
The case, one attornmey said, uniquely issues of administrative, agency and securities law—and how they apply to a deal made at a time when regulatory standards for the crypto industry are evolving.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now